Hosted on MSN
Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program
WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and outside experts, with some saying the poorly defined effort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results